(Q37775105)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20653987%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

review article

1 reference

title

Targeting tumour-initiating cells to improve the cure rates for triple-negative breast cancer (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20653987%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

author

Christopher A Maxwell

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20653987%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

author name string

Anna L Stratford

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20653987%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

Kristen Reipas

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20653987%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

Sandra E Dunn

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20653987%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

publication date

26 July 2010

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20653987%20AND%20SRC:MED&resulttype=core&format=json

Expert Reviews in Molecular Medicine

8 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20653987%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

volume

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20653987%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

page(s)

e22

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20653987%20AND%20SRC:MED&resulttype=core&format=json

Constitutively active type I insulin-like growth factor receptor causes transformation and xenograft growth of immortalized mammary epithelial cells and is accompanied by an epithelial-to-mesenchymal transition mediated by NF-kappaB and snail

8 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1017%2FS1462399410001535

Tumor development by transgenic expression of a constitutively active insulin-like growth factor I receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399410001535

Igf1r as a therapeutic target in a mouse model of basal-like breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399410001535

Phosphorylated insulin-like growth factor-i/insulin receptor is present in all breast cancer subtypes and is related to poor survival.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399410001535

Expression of the insulin-like growth factor I receptor and urokinase plasminogen activator in breast cancer is associated with poor survival: potential for intervention with 17-allylamino geldanamycin

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399410001535

EGFR associated expression profiles vary with breast tumor subtype

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399410001535

Epidermal growth factor receptor as a potential therapeutic target in triple-negative breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399410001535

Breast cancer cells with acquired resistance to the EGFR tyrosine kinase inhibitor gefitinib show persistent activation of MAPK signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399410001535

Preoperative gefitinib versus gefitinib and anastrozole in postmenopausal patients with oestrogen-receptor positive and epidermal-growth-factor-receptor-positive primary breast cancer: a double-blind placebo-controlled phase II randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399410001535

Gefitinib treatment in hormone-resistant and hormone receptor-negative advanced breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399410001535

Estrogen receptor, progesterone receptor, human epidermal growth factor receptor 2 (HER2), and epidermal growth factor receptor expression and benefit from lapatinib in a randomized trial of paclitaxel with lapatinib or placebo as first-line treatme

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399410001535

Phase III, double-blind, randomized study comparing lapatinib plus paclitaxel with placebo plus paclitaxel as first-line treatment for metastatic breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399410001535

A new model of patient tumor-derived breast cancer xenografts for preclinical assays

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399410001535

Basal-like breast cancer defined by five biomarkers has superior prognostic value than triple-negative phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399410001535

Epidermal growth factor receptor (EGFR) is transcriptionally induced by the Y-box binding protein-1 (YB-1) and can be inhibited with Iressa in basal-like breast cancer, providing a potential target for therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399410001535

Chemical genetics reveals a complex functional ground state of neural stem cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399410001535

Breast cancer stem cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399410001535

The cancer stem cell hypothesis: in search of definitions, markers, and relevance

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399410001535

Keeping abreast of the mammary epithelial hierarchy and breast tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399410001535

Therapeutic strategies for triple-negative breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399410001535

New concepts in breast cancer metastasis: tumor initiating cells and the microenvironment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399410001535

Identification of selective inhibitors of cancer stem cells by high-throughput screening

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399410001535

The prognostic role of a gene signature from tumorigenic breast-cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399410001535

CD44+/CD24- breast cancer cells exhibit enhanced invasive properties: an early step necessary for metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399410001535

High aldehyde dehydrogenase and expression of cancer stem cell markers selects for breast cancer cells with enhanced malignant and metastatic ability.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399410001535

The transcriptional induction of PIK3CA in tumor cells is dependent on the oncoprotein Y-box binding protein-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399410001535

Disruption of the Y-box binding protein-1 results in suppression of the epidermal growth factor receptor and HER-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399410001535

Two human genes isolated by a novel method encode DNA-binding proteins containing a common region of homology

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399410001535

Akt phosphorylates the Y-box binding protein 1 at Ser102 located in the cold shock domain and affects the anchorage-independent growth of breast cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399410001535

A method for quantifying normal human mammary epithelial stem cells with in vivo regenerative ability

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399410001535

The basic and clinical implications of ABC transporters, Y‐box‐binding protein‐1 (YB‐1) and angiogenesis‐related factors in human malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399410001535

Steroid hormone receptor status of mouse mammary stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399410001535

Nuclear localization and increased levels of transcription factor YB-1 in primary human breast cancers are associated with intrinsic MDR1 gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399410001535

YB-1 provokes breast cancer through the induction of chromosomal instability that emerges from mitotic failure and centrosome amplification.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399410001535

Downregulation of EZH2 decreases growth of estrogen receptor-negative invasive breast carcinoma and requires BRCA1

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399410001535

EZH2 is essential for glioblastoma cancer stem cell maintenance

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399410001535

EZH2 is a marker of aggressive breast cancer and promotes neoplastic transformation of breast epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399410001535

The transcriptional repressor Snail promotes mammary tumor recurrence

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399410001535

Roles of BRCA1 in DNA damage repair: a link between development and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399410001535

A mouse model of basal-like breast carcinoma with metaplastic elements

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399410001535

Oncolytic adenoviruses kill breast cancer initiating CD44+CD24-/low cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399410001535

Growth-inhibitory and tumor- suppressive functions of p53 depend on its repression of CD44 expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399410001535

Targeting of CD44 eradicates human acute myeloid leukemic stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399410001535

Y-box binding protein-1 induces the expression of CD44 and CD49f leading to enhanced self-renewal, mammosphere growth, and drug resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399410001535

Y-box binding protein-1 serine 102 is a downstream target of p90 ribosomal S6 kinase in basal-like breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399410001535

Association of breast cancer stem cells identified by aldehyde dehydrogenase 1 expression with resistance to sequential Paclitaxel and epirubicin-based chemotherapy for breast cancers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399410001535

The CD44+/CD24- phenotype is enriched in basal-like breast tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399410001535

Characterization of a naturally occurring breast cancer subset enriched in epithelial-to-mesenchymal transition and stem cell characteristics

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399410001535

Aurora-A kinase regulates breast cancer associated gene 1 inhibition of centrosome-dependent microtubule nucleation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399410001535

BRCA1 phosphorylation by Aurora-A in the regulation of G2 to M transition

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399410001535

Expression of human BRCA1 variants in mouse ES cells allows functional analysis of BRCA1 mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399410001535

Aurora kinases as anticancer drug targets

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399410001535

CD44 targeting reduces tumour growth and prevents post-chemotherapy relapse of human breast cancers xenografts.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399410001535

pp90rsk1 regulates estrogen receptor-mediated transcription through phosphorylation of Ser-167

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399410001535

Human breast cancer cell lines contain stem-like cells that self-renew, give rise to phenotypically diverse progeny and survive chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399410001535

BRCA1 regulates human mammary stem/progenitor cell fate

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399410001535

Depletion of BRCA1 impairs differentiation but enhances proliferation of mammary epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399410001535

Aberrant luminal progenitors as the candidate target population for basal tumor development in BRCA1 mutation carriers

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399410001535

Profiling YB-1 target genes uncovers a new mechanism for MET receptor regulation in normal and malignant human mammary cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399410001535

Survival of mammary stem cells in suspension culture: implications for stem cell biology and neoplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399410001535

Expression of aldehyde dehydrogenase 1 (ALDH1) is associated with basal-like markers and features of aggressive tumours in African breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399410001535

HER2 regulates the mammary stem/progenitor cell population driving tumorigenesis and invasion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399410001535

A clickable inhibitor reveals context-dependent autoactivation of p90 RSK

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399410001535

ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399410001535

BI-D1870 is a specific inhibitor of the p90 RSK (ribosomal S6 kinase) isoforms in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399410001535

Molecular definition of breast tumor heterogeneity

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399410001535

Ribosomal S6 kinase 2 is a key regulator in tumor promoter induced cell transformation

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399410001535

Breast cancer stem cells and intrinsic subtypes: controversies rage on.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399410001535

Fibroblast growth factor receptor 1-transformed mammary epithelial cells are dependent on RSK activity for growth and survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399410001535

Breast cancer stem cells: tools and models to rely on.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399410001535

Attenuation of proteasome-induced proteolysis in skeletal muscle by {beta}-hydroxy-{beta}-methylbutyrate in cancer-induced muscle loss

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399410001535

RSK1 drives p27Kip1 phosphorylation at T198 to promote RhoA inhibition and increase cell motility

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399410001535

The tumor suppressor DAP kinase is a target of RSK-mediated survival signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399410001535

Rsk1 mediates a MEK-MAP kinase cell survival signal

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399410001535

Inhibition of poly(ADP-ribose) polymerase in tumors from BRCA mutation carriers

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399410001535

A high-throughput pharmaceutical screen identifies compounds with specific toxicity against BRCA2-deficient tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399410001535

Pathologic complete response rates in young women with BRCA1-positive breast cancers after neoadjuvant chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399410001535

High sensitivity of BRCA1-deficient mammary tumors to the PARP inhibitor AZD2281 alone and in combination with platinum drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399410001535

Selective inhibition of BRCA2-deficient mammary tumor cell growth by AZD2281 and cisplatin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399410001535

Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399410001535

Specific killing of BRCA2-deficient tumours with inhibitors of poly(ADP-ribose) polymerase

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399410001535

Confirming the RNAi-mediated mechanism of action of siRNA-based cancer therapeutics in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399410001535

Targeting YB-1 in HER-2 overexpressing breast cancer cells induces apoptosis via the mTOR/STAT3 pathway and suppresses tumor growth in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399410001535

Redefining prognostic factors for breast cancer: YB-1 is a stronger predictor of relapse and disease-specific survival than estrogen receptor or HER-2 across all tumor subtypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399410001535

Frequent KIT and epidermal growth factor receptor overexpressions in undifferentiated-type breast carcinomas with 'stem-cell-like' features

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399410001535

Drug development of MET inhibitors: targeting oncogene addiction and expedience

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399410001535

Met induces mammary tumors with diverse histologies and is associated with poor outcome and human basal breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399410001535

Met induces diverse mammary carcinomas in mice and is associated with human basal breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399410001535

CD44 is required for two consecutive steps in HGF/c-Met signaling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399410001535

MET and MYC cooperate in mammary tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399410001535

Reversibility and recurrence of IGF-IR-induced mammary tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399410001535

Heterogeneity in cancer: cancer stem cells versus clonal evolution

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399410001535

Isolation and in vitro propagation of tumorigenic breast cancer cells with stem/progenitor cell properties

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399410001535

Prospective identification of tumorigenic breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399410001535

Cancer stem cells: an old idea--a paradigm shift

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399410001535

Intrinsic resistance of tumorigenic breast cancer cells to chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399410001535

The response of CD24(-/low)/CD44+ breast cancer-initiating cells to radiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399410001535

Triple-negative breast cancer: clinical features and patterns of recurrence

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399410001535

Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399410001535

Response to neoadjuvant therapy and long-term survival in patients with triple-negative breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399410001535

IkappaB alpha is a target for the mitogen-activated 90 kDa ribosomal S6 kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399410001535

Colorectal cancer stem cells are enriched in xenogeneic tumors following chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399410001535

Phosphorylation of the c-Fos transrepression domain by mitogen-activated protein kinase and 90-kDa ribosomal S6 kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399410001535

Residual breast cancers after conventional therapy display mesenchymal as well as tumor-initiating features

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399410001535

MAPK overexpression is associated with anthracycline resistance and increased risk for recurrence in patients with triple-negative breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399410001535

Breast cancer chemoresistance: emerging importance of cancer stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399410001535

Activation of the PTEN/mTOR/STAT3 pathway in breast cancer stem-like cells is required for viability and maintenance

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399410001535

Kinase mutations and imatinib response in patients with metastatic gastrointestinal stromal tumor

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399410001535

Successes and challenges in translational research: the development of targeted therapy for gastrointestinal stromal tumours.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399410001535

Immunohistochemical and clinical characterization of the basal-like subtype of invasive breast carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399410001535

Elimination of human lung cancer stem cells through targeting of the stem cell factor-c-kit autocrine signaling loop

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399410001535

Basal-like breast cancer and the BRCA1 phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399410001535

BRCA2 mutation-associated breast cancers exhibit a distinguishing phenotype based on morphology and molecular profiles from tissue microarrays

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399410001535

BRCA1 functions as a breast stem cell regulator

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399410001535

Genomic profiling of breast tumours in relation to BRCA abnormalities and phenotypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399410001535

BRCA1 and BRCA2: 1994 and beyond

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399410001535

Rational design of cationic lipids for siRNA delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399410001535

Triple-negative breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399410001535

New insights into RSK activation and hematopoietic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399410001535

7 January 2021

The serine/threonine protein kinase, p90 ribosomal S6 kinase, is an important regulator of prostate cancer cell proliferation

1 reference

https://api.crossref.org/works/10.1017%2FS1462399410001535

7 January 2021

Targeted chemotherapy? Platinum in BRCA1-dysfunctional breast cancer

1 reference

https://api.crossref.org/works/10.1017%2FS1462399410001535

7 January 2021

Expression of c-met is a strong independent prognostic factor in breast carcinoma

1 reference

https://api.crossref.org/works/10.1017%2FS1462399410001535

7 January 2021

Purification and unique properties of mammary epithelial stem cells

1 reference

https://api.crossref.org/works/10.1017%2FS1462399410001535

7 January 2021

Met expression is associated with poor outcome in patients with axillary lymph node negative breast carcinoma

1 reference

https://api.crossref.org/works/10.1017%2FS1462399410001535

7 January 2021

Novel cell culture technique for primary ductal carcinoma in situ: role of Notch and epidermal growth factor receptor signaling pathways

1 reference

https://api.crossref.org/works/10.1017%2FS1462399410001535

7 January 2021

Getting to the root of BRCA1-deficient breast cancer

1 reference

https://api.crossref.org/works/10.1017%2FS1462399410001535

7 January 2021

10.1017/S1462399410001535

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20653987%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

1 reference